Caricamento...
Latiglutenase Improves Symptoms in Seropositive Celiac Disease Patients While on a Gluten-Free Diet
BACKGROUND AND AIMS: Celiac disease (CD) is a widespread condition triggered by dietary gluten and treated with a lifelong gluten-free diet (GFD); however, inadvertent exposure to gluten can result in episodic symptoms. A previous trial of latiglutenase (clinicaltrials.gov; NCT01917630), an orally a...
Salvato in:
| Pubblicato in: | Dig Dis Sci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5709215/ https://ncbi.nlm.nih.gov/pubmed/28755266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-017-4687-7 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|